High-Performance Thin-Layer Chromatographic Method for Analysis of Racecadotril in the Bulk Drug

被引:1
作者
Prabu, Sakthivel Lakshmana [1 ]
Singh, Tarunveer [1 ]
Kumar, Chellappan Dinesh [1 ]
Joseph, Alex [1 ]
Srinivasan, Keloth Kaitheri [1 ]
机构
[1] Manipal Coll Pharmaceut Sci, Manipal 576104, Karnataka, India
关键词
Racecadotril; HPTLC; Validation; Stability indicating; Degradation; METABOLITE; HPLC;
D O I
10.1556/JPC.22.2009.4.7
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A new simple, rapid, reproducible, and stability-indicating high-performance thin-layer chromatographic method for analysis of racecadotril in the bulk drug and in a pharmaceutical formulation has been established and validated. Chromatographic separation was achieved on aluminum-backed silica gel 6017(254). HPTLC plates with n-hexane-ethyl acetate 70:30 (v/v) as mobile phase. The method gives a compact band for racecadotril (R-F 0.59 +/- 0.02) and enables excellent separation of its degradation products. Densitometric analysis of racceadotril was performed in absorbance mode at 230 nm. Linear regression analysis data for the calibration plots were indicative of a good linear relationship between peak area and concentration in the range 200-1600 ng per band (correlation coefficient 0.9975 +/- 0.0002); the mean value of the slope and intercept were 2.176 +/- 0.0239 and 88.98 +/- 2.797, respectively. The method was validated for accuracy, precision, and recovery. The limits of detection and quantification were 50 and 100 ng per band respectively. Racecadotril was subjected to acid and alkaline hydrolysis, and oxidative degradation. The drug undergoes degradation tinder acidic, basic, and oxidizing conditions. Statistical analysis proves the method enables repeatable, selective, and accurate analysis of racecadotril and can be used for identification and quantification of racecadotril in the bulk drug and in a commercial oral solid dosage form.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 10 条
[1]  
Cezard JP, 2005, INDIAN PEDIATR, V42, P502
[2]   Racecadotril [J].
Matheson, AJ ;
Noble, S .
DRUGS, 2000, 59 (04) :829-835
[3]  
Prabu S. L., 2007, Indian Journal of Pharmaceutical Sciences, V69, P819
[4]  
Prabu SL, 2008, ARS PHARM, V49, P211
[5]  
Reddy KM, 2006, PHARMAZIE, V61, P994
[6]   Racecadotril: a new approach to the treatment of diarrhoea [J].
Schwartz, JC .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (01) :75-79
[7]   Systematic review: racecadotril in the treatment of acute diarrhoea in children [J].
Szajewska, H. ;
Ruszczynski, M. ;
Chmielewska, A. ;
Wieczorek, J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (06) :807-813
[8]  
Vetrichelvan T., 2007, Indian Journal of Pharmaceutical Sciences, V69, P307
[9]   A rapid and validated HPLC method to quantify racecadotril metabolite, thiorphan, in human plasma using solid-phase extraction [J].
Xu, Fan ;
Yang, Lingli ;
Xu, Guili .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 861 (01) :130-135
[10]   Quantitative analysis of racecadotril metabolite in human plasma using a liquid chromatography/tandem mass spectrometry [J].
Xu, Yu ;
Huang, Jinchang ;
Liu, Fei ;
Gao, Shu ;
Guo, Qingxiang .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 852 (1-2) :101-107